Apheresis Market Size, Share, Growth Analysis, By Device(Leukapheresis, plasmapheresis, plateletpheresis, erythrocytapheresis), By Technology(Centrifugation and membrane separation), By Application(Renal disorders, hematological disorders, neurological disorders, autoimmune disorders), By Region - Industry Forecast 2024-2031

Apheresis Market size was valued at USD 2.79 billion in 2022 and is poised to grow from USD 3.10 billion in 2023 to USD 7.22 billion by 2031, at a CAGR of 11.15% during the forecast period (2024-2031).

The apheresis market is experiencing significant growth, driven by several factors. Firstly, the increasing burden of diseases and the rising demand for safe blood components are propelling the market forward.

Additionally, technological advancements in apheresis techniques are facilitating the development of new and improved procedures. Moreover, the implementation of favorable reimbursement policies and increased funding for apheresis procedures are supporting market growth.

Apheresis is increasingly being used as a primary or adjunct therapy for various diseases, including thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, drug toxicities, autoimmune diseases, sepsis, and fulminant hepatic failure. The versatility and efficacy of apheresis procedures contribute to their rising adoption in clinical settings.

Furthermore, product innovations and approvals play a significant role in driving market growth. Despite the positive growth prospects, the market faces certain challenges such as a shortage of skilled professionals, concerns related to blood contamination, and the associated costs of apheresis procedures. Overcoming these barriers will be crucial for sustaining the market's growth trajectory.

US Apheresis Market is poised to grow at a sustainable CAGR for the next forecast year.